Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Change in Accured Expenses (2021 - 2026)

HeartSciences filings provide 6 years of Change in Accured Expenses readings, the most recent being $68179.0 for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 333.05% to $68179.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $162008.0, a 200.12% increase, with the full-year FY2025 number at $16791.0, up 128.61% from a year prior.
  • Change in Accured Expenses hit $68179.0 in Q1 2026 for HeartSciences, up from -$334208.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $371484.0 in Q2 2022 to a low of -$477475.0 in Q3 2022.
  • Median Change in Accured Expenses over the past 5 years was $15744.0 (2025), compared with a mean of $12728.1.
  • Biggest five-year swings in Change in Accured Expenses: crashed 997.02% in 2022 and later surged 472.92% in 2025.
  • HeartSciences' Change in Accured Expenses stood at $247141.0 in 2022, then plummeted by 126.67% to -$65901.0 in 2023, then tumbled by 227.11% to -$215566.0 in 2024, then tumbled by 55.04% to -$334208.0 in 2025, then soared by 120.4% to $68179.0 in 2026.
  • The last three reported values for Change in Accured Expenses were $68179.0 (Q1 2026), -$334208.0 (Q4 2025), and $166718.0 (Q3 2025) per Business Quant data.